芪苈强心减轻阿霉素诱导的小鼠心脏损伤

doi:10.12066/j.issn.1007-2861.2015

上海大学学报(自然科学版) ›› 2018, Vol. 24 ›› Issue (2): 192-197.doi: 10.12066/j.issn.1007-2861.2015

芪苈强心减轻阿霉素诱导的小鼠心脏损伤

武晓栋¹, 姜惠敏², 姚文明¹, 高蓉蓉¹, 李新立¹()

1. 南京医科大学第一附属医院心脏内科, 南京 210029
2. 首都医科大学附属北京中医医院检验科, 北京 100010

收稿日期:2018-03-07 出版日期:2018-04-30 发布日期:2018-05-07
通讯作者: 李新立 E-mail:xinli3267@yeah.net
基金资助:
国家自然科学基金青年基金资助项目(81503283);国家自然科学基金重点资助项目(81730106)

Qiliqiangxin attenuates doxorubicin induced cardiac dysfunction in mice

WU Xiaodong¹, JIANG Huimin², YAO Wenming¹, GAO Rongrong¹, LI Xinli¹()

1. Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
2. Clinical Laboratory Center, Beijing Hospital of Traditional Chinese Medicine, Beijing 100010, China

Received:2018-03-07 Online:2018-04-30 Published:2018-05-07
Contact: LI Xinli E-mail:xinli3267@yeah.net

摘要/Abstract

摘要：

探讨了芪苈强心(Qiliqiangxin, QLQX)对阿霉素(doxorubicin, DOX)诱导的小鼠心功能下降的治疗作用. 选取 7~9 周雄性小鼠为实验对象, 将其随机分组, 通过每周腹腔注射一次阿霉素(4 mg/kg)构建小鼠心脏损伤模型, 治疗组同时口饲芪苈强心(0.5 g/(kg$\cdot$d)). 实验终点进行心脏超声检查. 实验结果表明, 芪苈强心可以减轻阿霉素诱导的心脏损伤, 保护小鼠心功能. 这提示芪苈强心有可能作为一种缓解阿霉素所致心脏损伤的药物.

关键词: 芪苈强心, 阿霉素, 心脏毒性, 线粒体

Abstract:

To investigate the therapeutic effects of Qiliqiangxin (QLQX) in doxorubicin (DOX)-induced cardiac dysfunction in vivo. Male mice aged 7~9 weeks were randomly divided into several groups. DOX (4 mg/kg) was injected to induce cardiotoxicity via intraperitoneal administration weekly, and QLQX was given by gavage every day for 4 weeks at a dose of 0.5 g/(kg$\cdot$d). After 4 weeks, echocardiography was performed to detect the cardiac function and it was showed that cardiac function could be significantly improved in mice treated with QLQX versus the saline. These findings indicated that QLQX could function as an intervening treatment for the patients who were treated with DOX.

Key words: Qiliqiangxin (QLQX), doxorubicin (DOX), cardiotoxicity, mitochondria

中图分类号:

R541

武晓栋, 姜惠敏, 姚文明, 高蓉蓉, 李新立. 芪苈强心减轻阿霉素诱导的小鼠心脏损伤[J]. 上海大学学报(自然科学版), 2018, 24(2): 192-197.

WU Xiaodong, JIANG Huimin, YAO Wenming, GAO Rongrong, LI Xinli. Qiliqiangxin attenuates doxorubicin induced cardiac dysfunction in mice[J]. Journal of Shanghai University（Natural Science Edition）, 2018, 24(2): 192-197.

图/表 5

参考文献 15

[1]	Carvalho F S, Burgeiro A, Garcia R, et al. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy[J]. Medicinal Research Reviews, 2014,34:106-135. pmid: 23494977
[2]	Arif I S, Hooper C L, Greco F, et al. Increasing doxorubicin activity against breast cancer cells using PPARgamma-ligands and by exploiting circadian rhythms[J]. British Journal of Pharmacology, 2013,169:1178-1188. doi: 10.1111/bph.12202 pmid: 23578093
[3]	Zhao L, Qi Y, Xu L, et al. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting nrf2 and sirt2[J]. Redox Biology, 2018,15:284-296. doi: 10.1016/j.redox.2017.12.013 pmid: 29304479
[4]	Li S, Wang W, Niu T, et al. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction[J]. Oxid Med Cell Longev, 2014,2014:748524. doi: 10.1155/2014/748524 pmid: 24895528
[5]	Steinherz L J, Steinherz P G, Tan C, et al. Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients[J]. Pediatric Blood & Cancer, 1995,24(6):352.
[6]	Cappetta D, De Angelis A, Sapio L, et al. Oxidative stress and cellular response to doxorubicin: a common factor in the complex milieu of anthracycline cardiotoxicity[J]. Oxid Med Cell Longev, 2017(16):1521020.
[7]	Fernandez-Chas M, Curtis M J, Niederer S A. Mechanism of doxorubicin cardiotoxicity evaluated by integrating multiple molecular effects into a biophysical model[J]. British Journal of Pharmacology, 2017, DOI: 10.1111/bph.14104. doi: 10.1111/bph.15186 pmid: 32608017
[8]	Li M S V, De Santis M C, Cimino J, et al. Phosphoinositide 3-kinase gamma inhibition protects from anthracycline cardiotoxicity and reduces tumor growth[J]. Circulation, 2018, DOI: 10.1161/CIRCULATIONAHA.117.030352. doi: 10.1161/CIRCULATIONAHA.119.045526 pmid: 32654539
[9]	Yuan Y P, Ma Z G, Zhang X, et al. Ctrp3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of sirt1[J]. Journal of Molecular and Cellular Cardiology, 2018,114:38-47. doi: 10.1016/j.yjmcc.2017.10.008 pmid: 29061338
[10]	Tony H, Yu K, Qiu T Z. MicroRNA-208a silencing attenuates doxorubicin induced myocyte apoptosis and cardiac dysfunction[J]. Oxid Med Cell Longev, 2015(17):597032.
[11]	Tao L, Shen S, Fu S, et al. Traditional Chinese medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice[J]. Scientific Reports, 2015, DOI: 10.1038/srep08374. doi: 10.1038/s41598-020-68334-2 pmid: 32665664
[12]	Lin S, Wu X, Tao L, et al. The metabolic effects of traditional Chinese medication Qiliqiangxin on h9c2 cardiomyocytes[J]. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2015,37:2246-2256.
[13]	Zhang J, Wei C, Wang H, et al. Protective effect of Qiliqiangxin capsule on energy metabolism and myocardial mitochondria in pressure overload heart failure rats[J]. Evidence-Based Complementary and Alternative Medicine, 2013,2013:378298. doi: 10.1155/2013/378298 pmid: 24078824
[14]	Yarana C, Carroll D, Chen J, et al. Extracellular vesicles released by cardiomyocytes in a doxorubicin-induced cardiac injury mouse model contain protein biomarkers of early cardiac injury[J]. Clinical Cancer Research, 2017, DOI: 10.1158/1078-0432.CCR-17-2046. doi: 10.1158/1078-0432.CCR-20-1828 pmid: 32611629
[15]	Khiati S, Dalla Rosa I, Sourbier C, et al. Mitochondrial topoisomerase 1 (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity[J]. Clinical Cancer Research, 2014,20:4873-4881. doi: 10.1158/1078-0432.CCR-13-3373 pmid: 24714774

芪苈强心减轻阿霉素诱导的小鼠心脏损伤

Qiliqiangxin attenuates doxorubicin induced cardiac dysfunction in mice

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 5

参考文献 15

相关文章 3

编辑推荐

Metrics

本文评价

[1]	后文琳, 潘雯, 付思艺, 宋美怡, 王菲. 小鼠非酒精性脂肪性肝炎中线粒体功能的障碍[J]. 上海大学学报(自然科学版), 2019, 25(1): 1-9.
[2]	李雨雨, 金由辛, 徐中娟, 张书忙, 索广力. ABL 沉默对 DOX 和 TRAIL 诱导结肠癌细胞 HT29 凋亡的影响[J]. 上海大学学报(自然科学版), 2018, 24(1): 134-141.
[3]	陶丽婵, 贾方. 运动训练对心脏衰老的保护机制[J]. 上海大学学报(自然科学版), 2017, 23(6): 828-.